MA28475B1 - Composés utiles pour le traitement de maladies - Google Patents

Composés utiles pour le traitement de maladies

Info

Publication number
MA28475B1
MA28475B1 MA29328A MA29328A MA28475B1 MA 28475 B1 MA28475 B1 MA 28475B1 MA 29328 A MA29328 A MA 29328A MA 29328 A MA29328 A MA 29328A MA 28475 B1 MA28475 B1 MA 28475B1
Authority
MA
Morocco
Prior art keywords
diseases
treatment
compounds useful
compounds
useful
Prior art date
Application number
MA29328A
Other languages
English (en)
Inventor
Alan Daniel Brown
Mark Edward Bunnage
Paul Alan Glossop
Kim James
Charlotte Alice Louise Lane
Russell Andrew Lewthwaite
Graham Lunn
David Anthony Price
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04290725A external-priority patent/EP1577291A1/fr
Priority claimed from GB0425064A external-priority patent/GB0425064D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of MA28475B1 publication Critical patent/MA28475B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA29328A 2004-03-17 2006-09-15 Composés utiles pour le traitement de maladies MA28475B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290725A EP1577291A1 (fr) 2004-03-17 2004-03-17 Dérivés béta-2 agonistes de la phényléthanolamine
US59179004P 2004-07-27 2004-07-27
GB0425064A GB0425064D0 (en) 2004-11-12 2004-11-12 Compounds useful for the treatment of diseases

Publications (1)

Publication Number Publication Date
MA28475B1 true MA28475B1 (fr) 2007-03-01

Family

ID=34961252

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29328A MA28475B1 (fr) 2004-03-17 2006-09-15 Composés utiles pour le traitement de maladies

Country Status (13)

Country Link
KR (1) KR20070026420A (fr)
AP (1) AP2006003743A0 (fr)
AR (1) AR048267A1 (fr)
EC (1) ECSP066854A (fr)
IL (1) IL177754A0 (fr)
MA (1) MA28475B1 (fr)
NL (1) NL1028559C2 (fr)
NO (1) NO20063875L (fr)
PA (1) PA8626401A1 (fr)
PE (1) PE20060123A1 (fr)
SV (1) SV2005002052A (fr)
TW (1) TWI281396B (fr)
UY (1) UY28810A1 (fr)

Also Published As

Publication number Publication date
AP2006003743A0 (en) 2006-10-31
PE20060123A1 (es) 2006-03-08
TW200534846A (en) 2005-11-01
ECSP066854A (es) 2006-11-24
UY28810A1 (es) 2005-10-31
TWI281396B (en) 2007-05-21
PA8626401A1 (es) 2006-05-16
AR048267A1 (es) 2006-04-12
SV2005002052A (es) 2005-12-13
NL1028559A1 (nl) 2005-09-20
KR20070026420A (ko) 2007-03-08
IL177754A0 (en) 2006-12-31
NO20063875L (no) 2006-09-26
NL1028559C2 (nl) 2006-04-19

Similar Documents

Publication Publication Date Title
FR13C0029I2 (fr) Compositions pour le traitement de troubles gastro-intestinaux
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
ATE478864T1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE424386T1 (de) Pyridin-verbindungen für die behandlung von prostaglandin-vermittelten krankheiten
DE602005001929D1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE371451T1 (de) Duale nk1/nk3 antagonisten zur behandlung von schizophrenie
MA28791B1 (fr) Derives de piperazine convenant pour le traitement de troubles gastro-intestinaux
FR22C1033I1 (fr) Utilisation de dihydroimidazolones pour le traitement des chiens
NL1028599A1 (nl) Verbindingen voor de behandeling van ziekten.
GB0329874D0 (en) Compounds useful for the treatment of diseases
ATE503752T1 (de) Sulfamide alsendothelinrezeptorantagonsiten zur behandlung von herzkreislauferkrankungen
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
GB0400802D0 (en) Compounds for the treatment of disease
ATE446757T1 (de) 1-ä2h-1-benzopyran-2-one-8-ylü- piperazinderivative zur behandlung von bewegungsstörungen
FR2868312B1 (fr) Patch pour le traitement des levres
FR2887456B1 (fr) "composition pour le traitement de la dermite estivale"
MA28475B1 (fr) Composés utiles pour le traitement de maladies
MA28482B1 (fr) Composés pour le traitement de maladies
ZA200606780B (en) Compounds for the treatment of diseases
AP2007004017A0 (en) Pyridine compounds for the treatment of prostaglandin mediated diseases
DE602004021568D1 (de) Thiadibenzoazulenderivate zur behandlung von entzündlichen erkrankungen
FR2875404B1 (fr) Composition pharmaceutique pour le traitement de la rosacee
DK1594498T3 (da) Anvendelse af etazolat til behandling af sygdomme
IS8496A (is) Samsetningar til meðhöndlunar á fjölgunarsjúkdómum